Phase I/II trial of autophagy inhibition in combination with neoadjuvant gemcitabine in patients with high-risk pancreatic adenocarcinoma: Safety, clinical response, and correlative studies

被引：3
|
作者：
Lotze, Michael T.
Boone, Brian A.
Zureikat, Amer H.
Bahary, Nathan
Lehman, David
Liotta, Lance A.
Zeh, Herbert J.
机构：
[1] Hillman Canc Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[4] George Mason Univ, Manassas, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.218
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
218
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II study of neoadjuvant durvalumab and tremelimumab in combination with gemcitabine and cisplatin in patients with intrahepatic cholangiocarcinoma that is borderline resectable or resectable with high risk for recurrence
    Sadagopan, Narayanan
    Weinberg, Benjamin Adam
    Noel, Marcus Smith
    Mukherji, Reetu
    Tesfaye, Anteneh A.
    Marshall, John
    Radkani, Pejman
    Guerra, Juan F.
    Nguyen, Brian M.
    Fishbein, Thomas M.
    He, Aiwu Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Phase II Clinical Trial of Alisertib, an Aurora a Kinase Inhibitor, in Combination with Induction Chemotherapy in High-Risk, Untreated Patients with Acute Myeloid Leukemia
    Brunner, Andrew M.
    Blonquist, Traci M.
    DeAngelo, Daniel J.
    McMasters, Malgorzata
    Winer, Eric S.
    Hobbs, Gabriela S.
    Amrein, Philip C.
    Hock, Hanno
    Steensma, David P.
    Garcia, Jacqueline S.
    Luskin, Marlise R.
    Stone, Richard M.
    Ballen, Karen K.
    Rosenblatt, Jacalyn
    Avigan, David E.
    McAfee, Steven L.
    Moran, Jenna A.
    Bergeron, Meghan
    Foster, Julia
    Bertoli, Christina
    McGregor, Kristin
    Fishman, Kaitlyn
    Macrae, Molly
    Burke, Meghan
    Behnan, Tanya T.
    Som, Tina T.
    Ramos, Aura Y.
    Vartanian, Megan K.
    Nelson, Nicole
    Logan, Emma
    Story, Jennifer Lombardi
    Connolly, Christine
    Neuberg, Donna S.
    Chen, Yi-Bin
    Graubert, Timothy A.
    Fathi, Amir T.
    BLOOD, 2018, 132
  • [43] Promising clinical activity of a NAB paclitaxel plus gemcitabine combination in a disease-specific phase I trial in patients with advanced pancreatic cancer
    Von Hoff, Daniel D.
    Borad, Mitesh
    Ramanathan, Ramesh K.
    Smith, Lon S.
    Drengler, Ronald L.
    Wood, Tina E.
    Laheru, Daniel
    Hidalgo, Manuel
    CANCER RESEARCH, 2008, 68 (09)
  • [44] A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study
    Fuyuhiko Motoi
    Sohei Satoi
    Goro Honda
    Keita Wada
    Hiroyuki Shinchi
    Ippei Matsumoto
    Masayuki Sho
    Akihiko Tsuchida
    Michiaki Unno
    Journal of Gastroenterology, 2019, 54 : 194 - 203
  • [45] A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study
    Motoi, Fuyuhiko
    Satoi, Sohei
    Honda, Goro
    Wada, Keita
    Shinchi, Hiroyuki
    Matsumoto, Ippei
    Sho, Masayuki
    Tsuchida, Akihiko
    Unno, Michiaki
    Kurata, M.
    Yanagimoto, H.
    Toyama, H.
    Nagakawa, Y.
    Maemura, K.
    Mataki, Y.
    Akahori, T.
    Kinoshita, S.
    Terashima, H.
    Horiguchi, A.
    Ohtsuka, Y.
    Nanashima, A.
    Kanemitsu, K.
    Ohigashi, H.
    Tani, M.
    Takahara, T.
    Shiomi, H.
    Endo, I.
    Suzuki, H.
    Rikiyama, T.
    Ikoma, H.
    Yasunaga, M.
    Nakamura, K.
    Egawa, S.
    Katayose, Y.
    Nakagawa, K.
    Okada, K.
    Ottomo, S.
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (02) : 194 - 203
  • [46] Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with Unfavorable and High-Risk Non-Metastatic Prostate Cancer: Feasibility And Safety
    Nickols, N. G.
    Kishan, A. U.
    Kane, N.
    Diaz-Perez, S.
    Ganapathy, E.
    Nazarian, R.
    Felix, C.
    Mathis, C.
    Kwak, J. Y.
    Basehart, V.
    Zomorodian, N.
    King, C. R.
    Kupelian, P. A.
    Rettig, M.
    Steinberg, M. L.
    Cao, M.
    Knudsen, B.
    Schaue, D.
    Reiter, R. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E298 - E298
  • [47] A phase II trial of neoadjuvant docetaxel and estramustine followed by radical prostatectomy or radiation therapy for patients with high-risk prostate cancer
    Goyal, L. K.
    Ramsey, S. N.
    Godley, P.
    Pruthi, R.
    Wallen, E.
    Whang, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S362 - S362
  • [48] Phase II Trial of Neoadjuvant Docetaxel and Gefitinib Followed by Radical Prostatectomy in Patients With High-Risk, Locally Advanced Prostate Cancer
    Vulky, Jacqueline
    Porter, Christopher
    Isacson, Christina
    Vaughan, Matthew
    Klowski, Paul
    Picozzi, Vincent
    Corman, John
    CANCER, 2009, 115 (04) : 784 - 791
  • [49] A Phase II Clinical Trial of Neoadjuvant Ketoconazole and Docetaxel Chemotherapy Before Radical Prostatectomy in High Risk Patients REPLY
    不详
    JOURNAL OF UROLOGY, 2011, 186 (03): : 888 - 888
  • [50] A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer.
    Lim, Sung Hee
    Yun, Jina
    Lee, Min-Young
    Kim, Han Jo
    Kim, Kyoung Ha
    Kim, Se Hyung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Hong, Dae Sik
    Choi, Hyun Jong
    Moon, Jong Ho
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345